Yiheng Capital Management, L.P. Dbv Technologies S.A. Transaction History

Yiheng Capital Management, L.P.

  • $1.95 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.75 - $0.95 $245,508 - $310,977
327,345 Added 6.25%
5,568,909 $4.18 Million
Q4 2023

Feb 14, 2024
BUY
$0.7 - $1.33 $3.58 Million - $6.79 Million
5,108,372 Added 3835.34%
5,241,564 $4.98 Million
Q3 2023

Nov 14, 2023
BUY
$1.3 - $1.88 $173,149 - $250,400
133,192 New
133,192 $181,000

Others Institutions Holding DBVT

# of Institutions
2
Shares Held
3.2K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $745M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Yiheng Capital Management, L.P. Portfolio

Follow Yiheng Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yiheng Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Yiheng Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email